JR
Johan Richter

Elite Scholar

228
Works
8,729
Citations
46
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Johan Richter

Also known as: J Richter, J. RICHTER, J. Richter, Johan Richter, Richter, J

228

Total Works

8,729

Citations

46

H-Index

120

i10-Index

Citation & Works Trend by Year
37 years active
Top Research Topics
Chronic Myeloid Leukemia Treatments (127) Chronic Lymphocytic Leukemia Research (84) Acute Myeloid Leukemia Research (56) Protein Tyrosine Phosphatases (46) Virus-based gene therapy research (39)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Comprehensive molecular characterization of treatment-free remission and molecular relapse in chronic myeloid leukemia patients: the EURO-SKI Biomarker Study Leukemia 3
2025 Deep single-cell immune and signaling profiles predict long term therapy response in chronic myeloid leukemia within hours bioRxiv (Cold Spring Harbor Laboratory) 0
2025 A randomized study of ropeginterferon in combination with bosutinib in newly diagnosed chronic myeloid leukemia (CML) patients in chronic Phase. the bosupeg trial from the Nordic CML study group Blood 0
2025 2025 European LeukemiaNet recommendations for the management of chronic myeloid leukemia Leukemia 145
2024 Author response: Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response eLife 1
2024 Single-cell multiomics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response eLife 9
2024 Health-related quality of life and symptoms of chronic myeloid leukemia patients after discontinuation of tyrosine kinase inhibitors: results from the EURO-SKI Trial Leukemia 15
2024 Reviewer #3 (Public Review): Single cell multi-omics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response eLife 0
2024 Author Response: Single cell multi-omics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response eLife 0
2024 Single cell multi-omics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response eLife 0
2024 Reviewer #1 (Public Review): Single cell multi-omics analysis of chronic myeloid leukemia links cellular heterogeneity to therapy response eLife 0
2024 European Stop Tyrosine Kinase Inhibitor Trial (EURO-SKI) in Chronic Myeloid Leukemia: Final Analysis and Novel Prognostic Factors for Treatment-Free Remission Journal of Clinical Oncology 71
2024 Correction: Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial Leukemia 0
2024 Treatment-free remission after a second TKI discontinuation attempt in patients with Chronic Myeloid Leukemia re-treated with dasatinib – interim results from the DAstop2 trial Leukemia 18
2024 How to interpret the EURO-SKI study and its treatment-free remission outcome. Reply to R.P. Gale and J. Chen Leukemia 2

Data source: OpenAlex API